https://powerfulpatients.org/pen/wp-content/uploads/ACTIVATED.png600600Kara Rayburnhttps://www.powerfulpatients.org/pen/wp-content/uploads/New-Logo-300x126.pngKara Rayburn2023-03-14 14:44:432023-05-23 09:51:33Becoming an Empowered and [ACT]IVATED AML Patient
https://powerfulpatients.org/pen/wp-content/uploads/12-Tips-to-Create-an-Educational-and-Inspiring-Roundup-of-Healthcare-News.png600600Marie Ennis-O'Connorhttps://www.powerfulpatients.org/pen/wp-content/uploads/New-Logo-300x126.pngMarie Ennis-O'Connor2023-03-10 10:22:392023-03-10 10:25:3012 Tips to Create an Educational and Inspiring Roundup of Healthcare News
https://powerfulpatients.org/pen/wp-content/uploads/February-2023-Digital-Health-Roundup.png600600Dana Kaiserhttps://www.powerfulpatients.org/pen/wp-content/uploads/New-Logo-300x126.pngDana Kaiser2023-02-27 10:04:432023-02-27 10:04:43February 2023 Digital Health Roundup
https://powerfulpatients.org/pen/wp-content/uploads/Arranging-Comprehensive-End-of-Life-Care-for-Elders-with-Cancer-1.png600600Miles Oliverhttps://www.powerfulpatients.org/pen/wp-content/uploads/New-Logo-300x126.pngMiles Oliver2023-02-15 09:46:252023-02-15 09:46:25Arranging Comprehensive End-of-Life Care for Elders with Cancer
https://powerfulpatients.org/pen/wp-content/uploads/Top-Two-Reasons-Why-CLL-Patients-Should-Participate-in-a-Clinical-Trial.png600600Kara Rayburnhttps://www.powerfulpatients.org/pen/wp-content/uploads/New-Logo-300x126.pngKara Rayburn2023-02-13 09:57:542023-02-13 09:57:54Top Two Reasons Why CLL Patients Should Participate in a Clinical Trial
https://powerfulpatients.org/pen/wp-content/uploads/January-2023-Digital-Health-Roundup.png600600Dana Kaiserhttps://www.powerfulpatients.org/pen/wp-content/uploads/New-Logo-300x126.pngDana Kaiser2023-01-23 09:36:242023-01-23 09:36:24January 2023 Digital Health Roundup
https://powerfulpatients.org/pen/wp-content/uploads/Quizartinib-in-FLT3-ITD-Positive-AML.png600600Art Flatauhttps://www.powerfulpatients.org/pen/wp-content/uploads/New-Logo-300x126.pngArt Flatau2023-01-10 10:39:512023-01-30 12:01:56Quizartinib in FLT3-ITD-Positive AML